---------- Forwarded message ----------
From: Kamayani <[email protected]>
Date: 7 March 2011 08:16
To:


Shameful past of medical trials prompts new US investigations

*The revelation that Americans infected Guatemalans with syphilis is a
terrible reminder of experiments on blacks, prisoners and the mentally ill,
and Obama is demanding action
*
*Mike Stobbe
*
*Sunday, 6 March 2011
*

Doctors exposed Illinois prisoners to malaria in the 1940s.

Shocking as it may seem, US government doctors once thought it acceptable to
experiment on disabled people and prison inmates. Such experiments included
giving hepatitis to mental patients in Connecticut, squirting a pandemic flu
virus up the noses of prisoners in Maryland, and injecting cancer cells into
chronically ill people at a New York hospital. At one point, pharmaceutical
company officials said they were using prisoners for testing because they
were cheaper than chimpanzees.

Much of this horrific history is at least 40 years old, but it was the
backdrop to a meeting in Washington last week of a presidential bioethics
commission. The gathering was triggered by the government's apology last
autumn for federal doctors having infected prisoners and mental patients in
Guatemala with syphilis 65 years ago. US officials also acknowledged there
had been dozens of similar experiments in America, which often involved
making healthy people sick.

A review by Associated Press of reports in medical journals and press
clippings has found more than 40 such studies. At best, these were part of
searches for life-saving treatments; at worst, they amounted to
curiosity-satisfying experiments that hurt people but provided no useful
results. Inevitably, they will be compared with the well-known Tuskegee
study. In that episode, US health officials tracked 600 black men in Alabama
who had syphilis but didn't give them adequate treatment, even after
penicillin became available.

The AP review found:

A federally-funded study begun in 1942 injected male patients at a state
insane asylum in Ypsilanti, Michigan, with an experimental flu vaccine, then
exposed them to flu several months later. It was co-authored by Dr Jonas
Salk, who, a decade later, would become famous as inventor of the polio
vaccine. Some of the men weren't able to describe their symptoms, raising
serious questions about how well they understood what was being done to
them. One newspaper account mentioned the test subjects were "senile and
debilitated".

The noted researcher Dr W Paul Havens Jnr, in federally-funded studies in
the 1940s, exposed men to hepatitis; in one he used patients from mental
institutions in Middletown and Norwich, Connecticut. Havens, a World Health
Organization expert on viral diseases, was one of the first scientists to
differentiate types of hepatitis and their causes. The study involving
mental patients made eight healthy men ill but broke no new ground in
understanding the disease.

Researchers in the mid-1940s studied the transmission of a deadly stomach
bug by having young men from New York State Vocational Institution, a
prison, swallow unfiltered stool suspension. The point was to see how well
the disease spread in comparison with having test subjects breathe germs in.
Swallowing was more effective, researchers concluded.

A University of Minnesota study in the late 1940s injected 11 public service
employee volunteers with malaria, then starved them for five days. Some were
also subjected to hard labour. They were treated with quinine sulphate. One
of the study's authors was Ancel Keys, a dietician who developed K-rations
for the military.

For a study in 1957, when the Asian flu pandemic was spreading, federal
researchers sprayed the virus in the noses of 23 inmates at Patuxent prison
in Jessup, Maryland, to compare their reactions to those of 32 virus-exposed
inmates who had been given a new vaccine.

Government researchers in the 1950s tried to infect about two dozen
volunteering inmates at a federal penitentiary in Atlanta with gonorrhea.
The bacteria was pumped into the urinary tract and the men quickly developed
the disease, but it was noted that this method wasn't comparable with the
way men normally became infected, by having sex with an infected partner.
The men were later treated with antibiotics.

Though people in the studies were usually described as volunteers,
historians and ethicists have questioned how well they understood what was
to be done to them and why, or whether they were coerced.

During the Second World War, prisoners were enlisted to help the war effort
by taking part in studies that could help the troops. For example, a series
of studies at Stateville Penitentiary in Illinois and two other prisons was
designed to test antimalarial drugs that could help soldiers fighting in the
Pacific.

The prosecution of Nazi doctors in 1947 led to the "Nuremberg Code", a set
of international rules to protect human test subjects. However, many
American doctors ignored them, arguing that they applied to Nazi atrocities,
not to US medicine.

The late 1940s and 1950s saw huge growth in America's pharmaceutical and
healthcare industries, accompanied by a boom in prisoner experiments funded
by both the government and corporations. By the 1960s, at least half the
states allowed inmates to be used as medical guinea pigs.

But two studies in the 1960s turned around public attitudes. The first came
to light in 1963. Researchers injected cancer cells into 19 old, debilitated
patients at Brooklyn's Jewish Chronic Disease Hospital in New York, to see
if their bodies would reject them. The hospital director said the patients
were not told they were being injected with cancer cells because there was
no need – the cells were deemed harmless. But the experiment upset a lawyer
named William Hyman who sat on the hospital's board of directors. After the
state investigated, the hospital declared that any future experiments would
require the patient's written consent.

Then, at nearby Staten Island, from 1963 to 1966, mentally retarded children
at Willowbrook State School were given hepatitis, orally and by injection,
to see if they could then be cured with gamma globulin.

Those two studies, along with the Tuskegee experiment, which came to light
in 1972, sparked extensive critical media coverage and public disgust, said
Susan Reverby, the Wellesley College historian who discovered records of the
syphilis study in Guatemala.

By the early 1970s, even experiments involving prisoners were considered
scandalous. In widely covered congressional hearings in 1973, pharmaceutical
industry officials acknowledged they were using prisoners for testing
because they were cheaper than chimpanzees. The government responded with
reforms. In the mid-1970s, the US Bureau of Prisons in effect excluded all
research by drug companies and other outside agencies within federal
prisons.

As the supply of prisoners and mental patients dried up, researchers looked
to other countries. Clinical trials could be done more cheaply and with
fewer rules. And it was easy to find patients who were taking no medication,
a factor that can complicate tests of other drugs.

Additional ethical guidelines have been enacted, and few believe that the
Guatemala study could happen today. Still, in the past 15 years two
international studies have sparked outrage. One was likened to Tuskegee:
US-funded doctors failed to give the Aids drug AZT to all HIV-positive
pregnant women in a study in Uganda, even though it would have protected
their newborns. US health officials said the study would answer questions
about AZT's use in the developing world.

The other study, by Pfizer, gave the antibiotic Trovan to children with
meningitis in Nigeria, although there were doubts about its effectiveness.
Critics blamed the experiment for the deaths of 11 children and the
disabling of scores of others. Pfizer settled a lawsuit with Nigerian
officials for $75m but admitted no wrongdoing.

Last year, the inspector-general of the US Department of Health and Human
Services reported that in 2008 between 40 and 65 per cent of clinical
studies of federally regulated medical products were conducted in other
countries; that proportion has probably grown. The report also noted that US
regulators inspected fewer than 1 per cent of foreign trial sites.

Monitoring research is complicated, and rules that are too rigid could slow
new drug development. It is often hard to get information on international
trials, sometimes because of missing records and a paucity of audits, says
Dr Kevin Schulman, a Duke University professor of medicine who has written
on the ethics of international studies.

These issues were still being debated when the Guatemala study came to light
last October. Between 1946 and 1948, American scientists infected prisoners
and patients in a mental hospital in Guatemala with syphilis, apparently to
test whether penicillin could prevent some sexually transmitted disease. The
study came up with no useful information and was hidden for decades. Beyond
infecting patients with a terrible illness, it was clear they did not
understand what was being done to them or were not able to give their
consent.

"When the President was briefed on the Guatemalan episode, one of his first
questions was whether this sort of thing could happen today," said Rick
Weiss, a spokesman for the White House. The administration asked its
bioethics panel to re-evaluate international medical studies. Barack Obama
also asked the Institute of Medicine to further probe the Guatemala study,
but the institute relinquished the assignment after reporting a conflict of
interest: in the 1940s, five members of a sister organisation had links to
the Guatemala study.

So the bioethics commission has been given both tasks. To focus on federally
funded international studies, the commission has formed an international
panel of about a dozen experts in ethics, science and clinical research. To
probe the Guatemala study, it has hired 15 staff investigators and is
working with historians and other experts. The panel is to report to the
President by Septembe

http://www.independent.co.uk/life-style/health-and-families/health-news/shameful-past-of-medical-trials-prompts-new-us-investigations-2233624.html


--
Adv Kamayani Bali Mahabal
+919820749204
skype-lawyercumactivist

-- 
You received this message because you are subscribed to the Google
Groups "Mental Health Advocacy (News 'N Views) India" group.
To post to this group, send email to [email protected]
To unsubscribe from this group, send email to
[email protected]
For more options, visit this group at
http://groups.google.com/group/MhaNewsViewsIndia?hl=en
-------------
Affiliated Groups :  MENTAL HEALTH ADVOCACY INDIA
[email protected]
Discussions on mental health law / policy / plan monitoring / human rights etc 
[email protected]
India-specific news and views related to mental health
[email protected]
Information and support to carers of people with mental health issues
[email protected]
Mutual support and sharing of experiential knowledge, skills and social 
learning amongst peers

Reply via email to